Langley Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Langley Wealth Management's GSK Position: Q3 2026 in Review
Langley Wealth Management increased its GSK (GSK) stake by 0.49% in Q3 2026, buying an estimated $1.12K and bringing the position to 4,489 shares worth $216K. The position accounts for 0.21% of the portfolio, ranked #106.
Langley Wealth Management first reported a position in GSK in Q2 2026 and has held it in 2 quarters since. The position peaked at $234K in Q2 2026. 990 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Langley Wealth Management held 4,489 shares of GSK worth $216K as of Q3 2026.
- Langley Wealth Management bought 22 GSK shares in Q3 2026, an estimated $1.12K.
- GSK made up 0.21% of Langley Wealth Management's portfolio in Q3 2026, its #106 holding.
- Langley Wealth Management first reported a position in GSK in Q2 2026 and has held it in 2 quarters since.
- Langley Wealth Management's GSK position peaked at $234K in Q2 2026.
- 990 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Langley Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.